Trieu Vuong - Jun 16, 2023 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Stock symbol
OTLC
Transactions as of
Jun 16, 2023
Transactions value $
$2,600
Form type
4
Date filed
6/20/2023, 12:00 PM
Previous filing
Jun 16, 2023
Next filing
Jun 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $2.6K +100K +0.11% $0.03 91.5M Jun 16, 2023 Direct
holding OTLC Common Stock 16.8M Jun 16, 2023 By Autotelic, Inc.
holding OTLC Common Stock 6.87M Jun 16, 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On June 16, 2023, Dr. Trieu purchased 100,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.026.